Susquehanna International Group’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39M Sell
769,549
-380,911
-33% -$659K ﹤0.01% 7079
2025
Q4
$1.55M Buy
1,150,460
+271,658
+31% +$387K ﹤0.01% 6165
2025
Q3
$1.43M Buy
878,802
+363,485
+71% +$403K ﹤0.01% 6501
2025
Q2
$500K Sell
515,317
-545,524
-51% -$452K ﹤0.01% 9175
2025
Q1
$749K Buy
1,060,841
+117,804
+12% +$81.5K ﹤0.01% 7983
2024
Q4
$759K Buy
943,037
+72,271
+8% +$66.2K ﹤0.01% 7631
2024
Q3
$864K Buy
870,766
+230,021
+36% +$316K ﹤0.01% 7148
2024
Q2
$993K Sell
640,745
-556,354
-46% -$867K ﹤0.01% 6613
2024
Q1
$1.96M Buy
1,197,099
+851,508
+246% +$714K ﹤0.01% 5391
2023
Q4
$199K Sell
345,591
-79,210
-19% -$31.7K ﹤0.01% 10693
2023
Q3
$170K Sell
424,801
-622,200
-59% -$307K ﹤0.01% 10414
2023
Q2
$569K Sell
1,047,001
-1,373,928
-57% -$881K ﹤0.01% 8005
2023
Q1
$2.07M Buy
2,420,929
+1,982,473
+452% +$2.16M ﹤0.01% 5057
2022
Q4
$570K Sell
438,456
-773,578
-64% -$1.21M ﹤0.01% 7512
2022
Q3
$2.16M Buy
1,212,034
+249,498
+26% +$621K ﹤0.01% 4763
2022
Q2
$2.19M Sell
962,536
-760,935
-44% -$1.82M ﹤0.01% 4720
2022
Q1
$5.69M Buy
1,723,471
+574,805
+50% +$2.02M ﹤0.01% 3423
2021
Q4
$5.23M Sell
1,148,666
-446,014
-28% -$3.37M ﹤0.01% 3669
2021
Q3
$11.4M Buy
1,594,680
+274,228
+21% +$2.01M ﹤0.01% 2673
2021
Q2
$10.6M Sell
1,320,452
-24,993
-2% -$211K ﹤0.01% 2834
2021
Q1
$9.14M Buy
+1,345,445
New +$8.95M ﹤0.01% 2917
2020
Q4
Sell
-22,032
Closed -$7K 11516
2020
Q3
$7K Buy
+22,032
New +$8.44K ﹤0.01% 10435
2020
Q2
Sell
-150,597
Closed -$42K 10671
2020
Q1
$42K Buy
+150,597
New +$74.8K ﹤0.01% 9742
2019
Q3
Sell
-1,497
Closed -$17K 10632
2019
Q2
$17K Sell
1,497
-14,704
-91% -$166K ﹤0.01% 10027
2019
Q1
$112K Buy
+16,201
New +$138K ﹤0.01% 8201
2018
Q3
Sell
-172
Closed -$26K 9937
2018
Q2
$26K Buy
+172
New +$26.7K ﹤0.01% 9395

Other funds holding OCGN

Susquehanna International Group's OCGN Position: Q1 2026 in Review

Susquehanna International Group reduced its Ocugen (OCGN) stake by 33% in Q1 2026, selling an estimated $659K and leaving 769,549 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #7079.

Susquehanna International Group first reported a position in OCGN in Q2 2018 and has held it in 26 quarters since. The position peaked at $11.4M in Q3 2021. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

  • Susquehanna International Group held 769,549 shares of Ocugen worth $1.39M as of Q1 2026.
  • Susquehanna International Group sold 380,911 Ocugen shares in Q1 2026, an estimated $659K.
  • Ocugen made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7079 holding.
  • Susquehanna International Group first reported a position in Ocugen in Q2 2018 and has held it in 26 quarters since.
  • Susquehanna International Group's Ocugen position peaked at $11.4M in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.